Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ralph Weissleder and Khalid Shah.
Connection Strength

2.727
  1. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci. 2008 Apr 23; 28(17):4406-13.
    View in: PubMed
    Score: 0.395
  2. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol Ther. 2005 Jun; 11(6):926-31.
    View in: PubMed
    Score: 0.323
  3. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx. 2005 Apr; 2(2):215-25.
    View in: PubMed
    Score: 0.320
  4. In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas. Cancer Res. 2004 Jan 01; 64(1):273-8.
    View in: PubMed
    Score: 0.293
  5. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene. 2003 Oct 09; 22(44):6865-72.
    View in: PubMed
    Score: 0.289
  6. A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. Stem Cells. 2010 Apr; 28(4):832-41.
    View in: PubMed
    Score: 0.113
  7. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene. 2010 Jun 03; 29(22):3185-95.
    View in: PubMed
    Score: 0.113
  8. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A. 2009 Mar 24; 106(12):4822-7.
    View in: PubMed
    Score: 0.105
  9. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. . 2008 Nov; 7(11):3575-85.
    View in: PubMed
    Score: 0.102
  10. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007 Oct 01; 67(19):8994-9000.
    View in: PubMed
    Score: 0.095
  11. Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo. Cancer Res. 2007 Aug 01; 67(15):7335-42.
    View in: PubMed
    Score: 0.094
  12. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia. 2007 May; 9(5):435-42.
    View in: PubMed
    Score: 0.092
  13. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol. 2005 Jan; 57(1):34-41.
    View in: PubMed
    Score: 0.079
  14. Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res. 2004 May 01; 64(9):3236-42.
    View in: PubMed
    Score: 0.075
  15. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res. 2004 Mar 01; 64(5):1579-83.
    View in: PubMed
    Score: 0.074
  16. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke. 2004 Apr; 35(4):952-7.
    View in: PubMed
    Score: 0.074
  17. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther. 2003 Sep 01; 14(13):1247-54.
    View in: PubMed
    Score: 0.072
  18. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia. 2004 Mar-Apr; 6(2):95-105.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.